Posard Matthew L. 4
4 · HALOZYME THERAPEUTICS, INC. · Filed Dec 6, 2022
Insider Transaction Report
Form 4
Posard Matthew L.
Director
Transactions
- Sale
Common Stock
2022-12-05$55.74/sh−10,000$557,370→ 115,189 total - Sale
Common Stock
2022-12-06$56.12/sh−10,000$561,180→ 105,189 total - Sale
Common Stock
2022-12-02$58.80/sh−10,000$588,000→ 125,189 total
Footnotes (3)
- [F1]Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.80 to $58.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $55.70 to $55.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Represents a weighted average sales price per share. The shares were sold at prices ranging from $56.10 to $56.19. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.